Amani Kitali, MBA, Mph, Pmp
About Amani Kitali, MBA, Mph, Pmp
Amani Kitali, MBA, MPH, PMP, is the Senior Director of US Medical Affairs Hematology, Multiple Myeloma Cell Therapy/CAR T at Bristol Myers Squibb in Summit, New Jersey. With over 15 years of experience in the biopharmaceutical industry, Kitali has a strong background in managing research programs and clinical trials in various therapeutic areas.
Current Role at Bristol Myers Squibb
Amani Kitali serves as Senior Director for US Medical Affairs in Hematology, focusing specifically on Multiple Myeloma Cell Therapy/CAR T at Bristol Myers Squibb in Summit, New Jersey. In this position, Kitali provides medical leadership for the Multiple Myeloma Cell Therapy Franchise, which includes ABECMA and GPRC5D CAR T therapies. This role involves leading medical strategies and overseeing key US medical activities, including upcoming product launches.
Professional Background
Amani Kitali has over 15 years of industry experience primarily in the biopharmaceutical sector. Before their current role, they held various positions at Bristol Myers Squibb and Celgene. Notably, they served as Director of CAR T Medical Strategies and Associate Director of Cellular Therapy Medical Strategies, as well as Senior Study Manager for Clinical Studies and Registries. Kitali has also worked at Writeresult LLC, Merck, and Schering Plough Research Institute in project management and analytical roles.
Educational Background
Amani Kitali holds an MBA from Rutgers Business School, completed between 2015 and 2017. They also earned an MPH in Global Health from the Yale School of Public Health from 2006 to 2008. Additionally, Kitali holds a B.Sc in Molecular Biophysics and Biochemistry from Yale University, which they achieved between 2003 and 2007. Their educational background is complemented by formal training in molecular biochemistry, epidemiology, public health, project management, and process improvement.
Research and Clinical Trial Management
Amani Kitali has extensive experience managing phase II-IV clinical trials across multiple therapeutic areas including Hematology, Oncology, Cardiovascular, CNS, Respiratory, Immunology, and Cellular Therapy. This includes a successful publication history in hematology research and demonstrated capabilities in conducting clinical lab research and epidemiology field research. Kitali's work involves building and managing cross-functional teams to identify project challenges and deliver results effectively.